Medical Research Infrastructures EATRIS, ECRIN and BBMRI sign long-term collaboration agreement

The Biobanking and BioMolecular resources Research Infrastructure (BBMRI), the European Research Infrastructure for Translational Medicine (EATRIS) and the European Clinical Research Infrastructure Network (ECRIN) signed an agreement last week in Brussels to build a long-term sustainable collaboration strategy. The agreement lays the ground for facilitating user access to pan-European medical research  infrastructures and supporting the development of tools, joint services and common approaches on quality, standards and advocacy. As a result, the agreement will empower BBMRI, EATRIS and ECRIN to provide even better services to the biomedical community and to support a more costeffective research and development process.


A member of NeurATRIS laureate 2018 of the Fondation Alzheimer

Benoît Larrat, researcher at Neurospin and member of NeurATRIS, is one of the 11 laureates 2018 of the Fondation Alzheimer with the TADUS project - Treating Alzheimer's Disease with Ultrasound.

More information about the project here.

"Mini-brains" for research on Alzheimer's disease

Researchers from SEPIA (François Jacob Institute of Biology) and CellTechs (Sup'Biotech engineering school), working in partnership with LEMM (Frédéric Joliot Institute for Life Sciences), all within or affiliated with the CEA, have developed a new approach for modeling Alzheimer's disease in vitro using human induced pluripotent stem cells (iPSCs). Their work builds upon the ability of iPSCs to differentiate into "mini-brains", that is, three-dimensional cellular structures recapitulating human brain development. 


Alzheimer : identification of aggregates of potential target proteins

The propagation of tau assemblies in the brain contributes to the progression of Alzheimer’s disease. Researchers from NeurATRIS, at the Neurodegenerative Diseases Laboratory: mechanisms, therapies, imaging (CNRS/CEA/Université Paris-Sud, MIRCen), working in collaboration with the Ecole Normale Supérieure, Sorbonne University and Inserm, have just identified the targets of these assemblies. Published in the EMBO Journal on January 10, 2019, this work will enable the development of tools capable of blocking these key elements of aggregate propagation and thus combating their pathological effect.

Read the complete press release on the CEA website.